DeBattista, Charles

A Comparison of Nefazodone, the Cognitive Behavioral-Analysis System of Psychotherapy, and Their Combination for the Treatment of Chronic Depression

Keller, M. B., McCullough, J. P., Klein, D. N., Arnow, B., Dunner, D. L., Gelenberg, A. J., Markowitz, J. C., Nemeroff, C. B., Russell, J. M., Thase, M. E., et al. (2000) · New England Journal of Medicine

Treatment of Major DepressionPsychotherapy Techniques and Applications

Cited by 1,331

Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression

Goodwin, G. M., Aaronson, S. T., Alvarez, O., Arden, P. C., Baker, A., Bennett, J. C., Bird, C., Blom, R. E., Brennan, C., Brusch, D., et al. (2022) · New England Journal of Medicine

Psychedelics and Drug StudiesTreatment of Major Depression

Cited by 1,167

Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression

Cole, E. J., Stimpson, K. H., Bentzley, B. S., Gulser, M., Cherian, K., Tischler, C., Nejad, R., Pankow, H., Choi, E., Aaron, H., et al. (2020) · American Journal of Psychiatry

Transcranial Magnetic Stimulation StudiesTreatment of Major Depression

Cited by 802

Stanford Neuromodulation Therapy (SNT): A Double-Blind Randomized Controlled Trial

Cole, E. J., Phillips, A. L., Bentzley, B. S., Stimpson, K. H., Nejad, R., Barmak, F., Veerapal, C., Khan, N., Cherian, K., Felber, E., et al. (2022) · American Journal of Psychiatry

Transcranial Magnetic Stimulation StudiesTreatment of Major Depression

Cited by 795

Subcallosal cingulate deep brain stimulation for treatment-resistant depression: a multisite, randomised, sham-controlled trial

Holtzheimer, P. E., Husain, M. M., Lisanby, S. H., Taylor, S. F., Whitworth, L. A., McClintock, S., Slavin, K. V., Berman, J., McKhann, G. M., Patil, P. G., et al. (2017) · The Lancet Psychiatry

Deep Brain Stimulation and Movement DisordersObsessive-Compulsive Spectrum Disorders

Cited by 577

Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)

Fava, M., Freeman, M. P., Flynn, M., Judge, H., Hoeppner, B. B., Cusin, C., Ionescu, D. F., Mathew, S. J., Chang, L. C., Iosifescu, D. V., et al. (2020) · Molecular Psychiatry

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 433

Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study

Greden, J. F., Parikh, S. V., Rothschild, A. J., Thase, M. E., Dunlop, B. W., DeBattista, C., Conway, C. R., Forester, B. P., Mondimore, F. M., Shelton, R. C., et al. (2019) · Journal of Psychiatric Research

Treatment of Major DepressionPharmacogenetics and Drug Metabolism

Cited by 347

An open label trial of C-1073 (mifepristone) for psychotic major depression*

Belanoff, J. K., Rothschild, A. J., Cassidy, F., DeBattista, C., Baulieu, E.-E., Schold, C., & Schatzberg, A. F. (2002) · Biological Psychiatry

Treatment of Major DepressionSchizophrenia research and treatment

Cited by 320

Childhood trauma predicts antidepressant response in adults with major depression: data from the randomized international study to predict optimized treatment for depression

Williams, L. M., Debattista, C., Duchemin, A.-M., Schatzberg, A. F., & Nemeroff, C. B. (2016) · Translational Psychiatry

Treatment of Major DepressionChild Abuse and Trauma

Cited by 293

The Texas Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive Disorder

Crismon, M. L., Trivedi, M., Pigott, T. A., Rush, A. J., Hirschfeld, R. M. A., Kahn, D. A., DeBattista, C., Nelson, J. C., Nierenberg, A. A., Sackeim, H. A., et al. (1999) · The Journal of Clinical Psychiatry

Treatment of Major DepressionMental Health Treatment and Access

Cited by 250

Mifepristone versus Placebo in the Treatment of Psychosis in Patients with Psychotic Major Depression

DeBattista, C., Belanoff, J., Glass, S., Khan, A., Horne, R. L., Blasey, C., Carpenter, L. L., & Alva, G. (2006) · Biological Psychiatry

Treatment of Major DepressionSchizophrenia research and treatment

Cited by 162

The International Study to Predict Optimized Treatment in Depression (iSPOT-D): Outcomes from the acute phase of antidepressant treatment

Saveanu, R., Etkin, A., Duchemin, A.-M., Goldstein-Piekarski, A., Gyurak, A., Debattista, C., Schatzberg, A. F., Sood, S., Day, C. V. A., Palmer, D. M., et al. (2015) · Journal of Psychiatric Research

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 151

A Prospective Trial of Modafinil as an Adjunctive Treatment of Major Depression

DeBattista, C., Lembke, A., Solvason, H. B., Ghebremichael, R., & Poirier, J. (2004) · Journal of Clinical Psychopharmacology

Treatment of Major DepressionAttention Deficit Hyperactivity Disorder

Cited by 144

The neuropsychological profile of psychotic major depression and its relation to cortisol

Gomez, R. G., Fleming, S. H., Keller, J., Flores, B., Kenna, H., DeBattista, C., Solvason, B., & Schatzberg, A. F. (2006) · Biological Psychiatry

Stress Responses and CortisolTreatment of Major Depression

Cited by 127

Executive dysfunction in major depressive disorder

DeBattista, C. (2005) · Expert Review of Neurotherapeutics

Treatment of Major DepressionNeural and Behavioral Psychology Studies

Cited by 62

A multisite trial of mifepristone for the treatment of psychotic depression: A site-by-treatment interaction

Blasey, C. M., DeBattista, C., Roe, R., Block, T., & Belanoff, J. K. (2009) · Contemporary Clinical Trials

Treatment of Major DepressionStatistical Methods in Clinical Trials

Cited by 61

Combinatorial Pharmacogenomic Algorithm is Predictive of Citalopram and Escitalopram Metabolism in Patients with Major Depressive Disorder

Shelton, R. C., Parikh, S. V., Law, R. A., Rothschild, A. J., Thase, M. E., Dunlop, B. W., DeBattista, C., Conway, C. R., Forester, B. P., Macaluso, M., et al. (2020) · Psychiatry Research

Pharmacogenetics and Drug MetabolismGenetic Associations and Epidemiology

Cited by 31

Clinical validation of combinatorial pharmacogenomic testing and single-gene guidelines in predicting psychotropic medication blood levels and clinical outcomes in patients with depression

Rothschild, A. J., Parikh, S. V., Hain, D., Law, R., Thase, M. E., Dunlop, B. W., DeBattista, C., Conway, C. R., Forester, B. P., Shelton, R. C., et al. (2021) · Psychiatry Research

Pharmacogenetics and Drug MetabolismTreatment of Major Depression

Cited by 20

35. Efficacy of Ketamine in Unmedicated Adults With OCD: A Randomized Controlled Trial

Rodriguez, C., Chen, C.-M., Glover, G., Jo, B., Spielman, D., Williams, L., van Roessel, P., DeBattista, C., Wintermark, M., Lombardi, A., et al. (2023) · Biological Psychiatry

Obsessive-Compulsive Spectrum DisordersTreatment of Major Depression

Cited by 0